Viemed Healthcare (VMD) to Release Quarterly Earnings on Tuesday

Viemed Healthcare (NASDAQ:VMD - Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, May 7th. Viemed Healthcare has set its Q1 2024 guidance at EPS.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last announced its quarterly earnings results on Wednesday, March 6th. The company reported $0.09 earnings per share for the quarter. The business had revenue of $50.74 million for the quarter. Viemed Healthcare had a net margin of 5.60% and a return on equity of 9.59%.

Viemed Healthcare Stock Down 0.4 %

VMD traded down $0.03 during mid-day trading on Tuesday, reaching $8.19. 100,947 shares of the stock were exchanged, compared to its average volume of 155,701. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.05 and a current ratio of 1.19. The company has a 50 day moving average price of $8.78 and a two-hundred day moving average price of $8.05. Viemed Healthcare has a 1 year low of $5.90 and a 1 year high of $11.27. The stock has a market capitalization of $317.44 million, a PE ratio of 32.04 and a beta of 1.51.

Viemed Healthcare Company Profile

(Get Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Featured Articles

Earnings History for Viemed Healthcare (NASDAQ:VMD)

Should you invest $1,000 in Viemed Healthcare right now?

Before you consider Viemed Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.

While Viemed Healthcare currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: